Disease severity and response to treatment in Iranian patients with myasthenia gravis

ConclusionsThe overall outcome was favorable in the majority of patients, despite differences in the disease course and severity. In contrary to the previous reports, anti-MuSK positive patients in our series did not need a more vigorous treatment regimen comparing other serologic subtypes of MG.
Source: Neurological Sciences - Category: Neurology Source Type: research